Trial
NCT05369832
An Open-label Study of Ozanimod in Moderate to Severe Ulcerative Colitis in Clinical Practice
Phase IVTERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Bristol-Myers Squibb
Collaborators
—
Condition
Colitis, Ulcerative
Intervention
Ozanimod
Why stopped
Business objectives have changed.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-02-10